ARTICLE | Company News
CURx Pharma Inc., ImmuCell, Novatreat Ltd. deal
December 23, 2002 8:00 AM UTC
Novatreat terminated its 2001 license for ICCC's DiffGAM bovine anti-Clostridium difficile immunoglobulins for functional food applications outside of North America. ICCC received a $400,000 termination fee. ...